iTeos Therapeutics (ITOS)
(Delayed Data from NSDQ)
$13.64 USD
+0.47 (3.57%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $13.63 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/8/24 |
---|---|
Current Quarter | -1.02 |
EPS Last Quarter | -0.85 |
Last EPS Surprise | 17.48% |
ABR | 1.00 |
Earnings ESP
|
2.94% |
---|---|
Current Year | -4.76 |
Next Year | -6.19 |
EPS (TTM) | -3.15 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | 6.30M | 56.30M | 20.31M |
# of Estimates | NA | 1 | 2 | 2 |
High Estimate | NA | 6.30M | 100.00M | 37.41M |
Low Estimate | NA | 6.30M | 12.60M | 3.20M |
Year ago Sales | 12.60M | 0.00M | 12.60M | 56.30M |
Year over Year Growth Est. | NA | NA | 347.00% | -63.93% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.02 | -1.04 | -4.76 | -6.19 |
# of Estimates | 4 | 4 | 5 | 5 |
Most Recent Consensus | -1.22 | -1.34 | -5.61 | -7.57 |
High Estimate | -0.86 | -0.67 | -3.37 | -3.01 |
Low Estimate | -1.22 | -1.34 | -5.92 | -8.35 |
Year ago EPS | -0.44 | -0.96 | -3.15 | -4.76 |
Year over Year Growth Est. | -131.82% | -8.33% | -51.11% | -30.04% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 3 | 2 | 2 | 2 |
Up Last 60 Days | 3 | 2 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 2 | 2 | 1 |
Down Last 60 Days | 0 | 2 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.02 | -1.04 | -4.76 | -6.19 |
7 Days Ago | -1.02 | -1.04 | -4.76 | -6.19 |
30 Days Ago | -1.13 | -1.01 | -4.85 | -6.42 |
60 Days Ago | -1.13 | -1.01 | -5.43 | -6.39 |
90 Days Ago | -1.13 | -1.01 | -5.43 | -6.39 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.99 | -1.04 | -4.47 | -5.01 |
Zacks Consensus Estimate | -1.02 | -1.04 | -4.76 | -6.19 |
Earnings ESP | 2.94% | 0.00% | 6.11% | 19.09% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.85 | -0.90 | -0.96 | -0.44 | NA |
Estimate | -1.03 | -1.20 | -1.03 | -0.99 | NA |
Difference | 0.18 | 0.30 | 0.07 | 0.55 | 0.28 |
Surprise | 17.48% | 25.00% | 6.80% | 55.56% | 26.21% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more